ASTRAZENECA PLC 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 06:00 am Sale | 2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT | ASTRAZENECA PLC | 4,926 1.100% | -1,410 (-22.26%) | Filing |
| 2024-10-11 06:01 am Purchase | 2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT | ASTRAZENECA PLC | 6,336 9.900% | 6,336 (New Position) | Filing |